SUMMARY
The results of a field experiment with winter barley in which severe mildew occurred early in the autumn are described. Where the disease was controlled with ethirimol (‘Milstem’)* seed dressing, the production of adventitious roots and tillers in the autumn was significantly increased and more of the tillers developed to maturity leading to higher grain yields.
Field and greenhouse studies were conducted to evaluate selected PRE-applied herbicides for sprangletop control. In greenhouse studies, oxadiazon and dithiopyr provided excellent (> 89%) red sprangletop (L. filiformis) control. Pendimethalin and metolachlor + atrazine provided good (80–89%) to excellent control for 6 mo and 2 mo during studies 1 and 2, respectively. Isoxaben and atrazine provided poor (< 70%) control during both greenhouse studies. In field studies, good to excellent bearded sprangletop (L. fascicularis) control followed dithiopyr, pendimethalin, metolachlor, and metolachlor + atrazine treatments. Dithiopyr at 0.8 kg ai/ha provided best (> 95%) sprangletop control throughout the 6-mo testing period. Under field conditions, control was inconsistent following oxadiazon with good to excellent control during one study and poor control in another study. Better or equal control than metolachlor + atrazine followed dithiopyr, pendimethalin, and metolachlor alone treatments. Oxadiazon also provided similar or better control than metolachlor+atrazine in three of four studies. Over all studies, dithiopyr provided best sprangletop control, followed by metolachlor, metolachlor + atrazine, pendimethalin, and oxadiazon. Isoxaben and atrazine treatments provided poorest or inconsistent sprangletop control.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.